BioSpace News Archive

The global predictive genetic testing and consumer/wellness genomics market is estimated to expand at a CAGR of 13.9% during the forecast period of 2019 to 2025.

Albany NY, United States: Podiatry is the branch of medicine concerning the foot, ankle, and lower extremities.

Albany NY, United States: A trocar is a pen-shaped medical device that provides access to the abdominal cavity during a laparoscopic surgery.

RELIEF THERAPEUTICS Holding SA, a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need, gives notice of the Annual General Meeting of shareholders to be held on May 31, 2022.

Acer Therapeutics Inc. and its collaboration partner, Relief Therapeutics Holding SA, announced the presentation of data evaluating the bioavailability, bioequivalence and taste attributes of ACER-001 compared to sodium phenylbutyrate powder during poster sessions at the recent Genetic Metabolic Dieticians International Conference on May 5, 2022, in Las Vegas, Nevada.

Orion Corporation has entered into an agreement with Chinese Jemincare, through which Orion will receive exclusive global development and commersialisation rights, excluding the Greater China area, for a potent and selective NaV 1.8 blocker for the treatment of acute and chronic pain.

BioArctic AB announced that the US Patent and Trademark Office has granted a new drug substance patent for the antibody ABBV-0805, invented by BioArctic as a potential treatment of Parkinson’s disease.

Global health services company Cigna Corporation reported strong first quarter 2022 results reflecting revenue and earnings growth across its businesses.

Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, is aware that the Company has been identified by the United States Securities and Exchange Commission (“SEC”) under the Holding Foreign Companies Accountable Act of the United States (the “HFCAA”) on May 4, 2022.

Ocugen, Inc. reported first quarter 2022 financial results along with a general business update.